Atlas Trials

Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis

Clinical trial NCT03850483 · COMPLETED

Trial details

NCT number
NCT03850483
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Psoriasis
Start date
2019-04-08
Primary completion
2021-04-20
Enrollment
344

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.